Author Question: Although unusually high, extinction rates may be A) declining because of overestimates of some ... (Read 15 times)

codyclark

  • Hero Member
  • *****
  • Posts: 538
Although unusually high, extinction rates may be
 
  A) declining because of overestimates of some groups in some ecosystems.
  B) declining because fewer species are becoming threatened worldwide.
  C) even higher because of the loss of tropical forests.
  D) even higher because of intense predation in many grassland ecosystems.

Question 2

In general, the species most vulnerable to extinction are those that are
 
  A) endemic, highly specialized, or limited to a single population.
  B) endemic and widespread in several large regions.
  C) genetically diverse and found in many regions.
  D) widespread but are not dominant in an ecosystem.



jazzlynnnnn

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

C

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library